tisagenlecleucel < tissue < tissues

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references

Number of relevant bibliographic references: 29.
[0-20] [0 - 20][0 - 29][20-28][20-40]

Ident.	Authors (with country if any)	Title
000001 (2020)	A. Prasse [Allemagne] ; F. Bonella [Allemagne] ; U. Müller-Ladner [Allemagne] ; T. Witte [Allemagne] ; N. Hunzelmann [Allemagne] ; J. Distler [Allemagne]	[Treatment of systemic sclerosis-associated interstitial lung disease].
000003 (2020)	Charlotte Girard-Guyonvarc'H ; Michele Iudici	[Targeted therapies for connective tissue diseases and vasculitis].
000006 (2020)	Anna Jakubczyc ; Claus Neurohr	[Interstitial lung disease in rheumatic diseases - new therapeutic approaches].
000018 (2020)	Emily Liang [États-Unis] ; Mihaela Taylor [États-Unis] ; Maureen Mcmahon [États-Unis]	Utility of the AVISE Connective Tissue Disease test in predicting lupus diagnosis and progression
000027 (2020)	Shanshan Deng [États-Unis, République populaire de Chine] ; Michael J. Clowers [États-Unis] ; Walter V. Velasco [États-Unis] ; Marco Ramos-Castaneda [États-Unis] ; Seyed Javad Moghaddam [États-Unis]	Understanding the Complexity of the Tumor Microenvironment in K-ras Mutant Lung Cancer: Finding an Alternative Path to Prevention and Treatment
000070 (2020)	Yasmine F. Ibrahim [Égypte] ; Rabab A. Moussa [Égypte] ; Asmaa M A. Bayoumi [Égypte] ; Al-Shaimaa F. Ahmed [Égypte]	Tocilizumab attenuates acute lung and kidney injuries and improves survival in a rat model of sepsis via down-regulation of NF-κB/JNK: a possible role of P-glycoprotein.
000079 (2020)	Caterina Vacchi [Italie] ; Marco Sebastiani [Italie] ; Giulia Cassone [Italie] ; Stefania Cerri [Italie] ; Giovanni Della Casa [Italie] ; Carlo Salvarani [Italie] ; Andreina Manfredi [Italie]	Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review
000081 (2020)	Francisco Vílchez-Oya [Espagne] ; Julia María Sánchez-Schmidt [Espagne] ; Anna Agustí [Espagne] ; Ana Pros [Espagne]	The use of tocilizumab in the treatment of refractory eosinophilic fasciitis: a case-based review.
000086 (2020)	Christine Brostjan ; Rudolf Oehler	The role of neutrophil death in chronic inflammation and cancer
000089 (2020)	Jacob J. Adashek [États-Unis] ; Shumei Kato [États-Unis] ; Scott M. Lippman [États-Unis] ; Razelle Kurzrock [États-Unis]	The paradox of cancer genes in non-malignant conditions: implications for precision medicine
000109 (2020)	Eric Toussirot [France]	The Interrelations between Biological and Targeted Synthetic Agents Used in Inflammatory Joint Diseases, and Obesity or Body Composition
000144 (2020)	Wolfgang F. Richter [Suisse] ; Hans-Peter Grimm [Suisse] ; Marie-Hélène Gouy [Suisse] ; Susi S Gaard [Danemark] ; Caroline Kreuzer [Suisse] ; Uwe Wessels [Allemagne] ; Dragomir Draganov [Suisse] ; Chris Muenzer [Suisse] ; Tonio Hoche [Suisse]	Subcutaneous Site-of-Absorption Study with the Monoclonal Antibody Tocilizumab in Minipigs: Administration Behind Ear Translates Best to Humans.
000244 (2020)	Przemysław Błyszczuk [Suisse, Pologne] ; Zoltan Szekanecz [Hongrie]	Pathogenesis of ischaemic and non-ischaemic heart diseases in rheumatoid arthritis
000263 (2020)	Gilson Gonçalves Dos Santos [États-Unis] ; Lauriane Delay [États-Unis] ; Tony L. Yaksh [États-Unis] ; Maripat Corr [États-Unis]	Neuraxial Cytokines in Pain States
000286 (2020)	Tiago Torres [Portugal] ; Luis Puig [Espagne]	Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic
000327 (2020)	Jakob Einhaus [Allemagne] ; Ann-Christin Pecher [Allemagne] ; Elisa Asteriti [Allemagne] ; Hannes Schmid [Allemagne] ; Kathy-Ann Secker [Allemagne] ; Silke Duerr-Stoerzer [Allemagne] ; Hildegard Keppeler [Allemagne] ; Reinhild Klein [Allemagne] ; Corina Schneidawind [Allemagne] ; Joerg Henes [Allemagne] ; Dominik Schneidawind [Allemagne]	Inhibition of effector B cells by ibrutinib in systemic sclerosis
000348 (2020)	Sisi Xie ; Shu Li ; Jing Tian ; Fen Li	Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape
000352 (2020)	Sakthi Rajendran [États-Unis] ; Florence Anquetil [États-Unis] ; Estefania Quesada-Masachs [États-Unis] ; Madeleine Graef [États-Unis] ; Nathaly Gonzalez [États-Unis] ; Sara Mcardle [États-Unis] ; Tiffany Chu [États-Unis] ; Lars Krogvold [Norvège] ; Knut Dahl-J Rgensen [Norvège] ; Matthias Von Herrath [États-Unis]	IL-6 is present in beta and alpha cells in human pancreatic islets: Expression is reduced in subjects with type 1 diabetes.
000389 (2020)	Koichi Nakamura ; Tomoki Nakamura ; Takahiro Iino ; Tomohito Hagi ; Kouji Kita ; Kunihiro Asanuma ; Akihiro Sudo	Expression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas
000411 (2020)	Lutz Wollin [Allemagne] ; Dieudonnée Togbe [France] ; Bernhard Ryffel [France]	Effects of Nintedanib in an Animal Model of Liver Fibrosis
000414 (2020)	Guiomar Pinheiro [Portugal] ; Ana Rita Costa [Portugal] ; Ana Campar [Portugal] ; Teresa Mendonça [Portugal]	Effectiveness of Tocilizumab in the Treatment of Fasciitis with Eosinophilia: Two Case Reports

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "tissue" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "tissue" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    tissue
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021